Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Serebruany, VL; O'Connor, CM; Krishnan, RR; Hennekens, CH

Published Date

  • September 2005

Published In

Volume / Issue

  • 10 / 3

Start / End Page

  • 163 - 164

PubMed ID

  • 16211204

Pubmed Central ID

  • 16211204

International Standard Serial Number (ISSN)

  • 1074-2484

Digital Object Identifier (DOI)

  • 10.1177/107424840501000303

Language

  • eng

Conference Location

  • United States